AFRICA CLINICAL NETWORK
Today’s rapid developments in health care research and biomedical science and trends in globalisation have led to increased awareness of health inequities and the need for efforts to improve health around the world. Intensive cross-border cooperation is required to address this worldwide inequity in access to health care.    
Therefor Africa Clinical has been set up. Africa Clinical is a network of local investigators and institutes established in 2017 by Julius Clinical together with Julius Global Health. The aim is to have a solid and continent-wide network of local investigators and institutes in Africa providing access to suitable sites and patients when planning a clinical trial in Sub-Saharan countries. Currently, it consists of 243 public hospitals & research Institutes in 20 different countries of Africa with experience in performing clinical trials and clinical research staff. Africa Clinical is managed and governed by Julius Clinical. ​
" Be the change that you wish to see in the world."
​- Mahatma Ghandi -
Julius Global Health organises an evening course which takes place the second Wednesday of every month, from 19:00-21:30. Every lecture discusses a different key topic in global health.
The course is aimed mainly at Medicine students, students from other faculties, UMCU and UU staff, but it is open to anyone interested in Global Health. Participants who attend eight evenings and write an essay about one of the lectures can receive a certificate for the course.
Find out more information about the course on the UU website, the Global Health Facebook page, or send questions to international.office@umcutrecht.nl

THE Organisational parties

Julius Clinical is a research organisation that is able to combine the latest scientific insights with operational excellence to find credible, creative, cost-effective solutions for clinical trials. 
We have a strong and committed network of academic leaders and investigators around the world in a variety of therapeutic areas. We offer end-to-end CRO services in specific therapeutic areas based on our scientific expertise. 
Julius Global Health is part of the Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht in The Netherlands and aims to conduct high-impact (clinical) epidemiologic and public health research that generates evidence contributing to improved individual and public health and to educate new generations of researchers and health care professionals across the globe. Global health research activities are concentrated in Africa, Asia, and Oceania and focus on circulatory health, cancer, infectious disease, maternal and child health, as well as environmental health.
The ReSViNET Foundation is the international leading non-profit organization committed to reducing the global burdens of RSV infection. RSV acute lower respiratory infection (ALRI) is one of the most significant global healthcare challenges, not only in infants, but also in older adults and no vaccine is licensed for prevention. It is already affecting 33.1 million children under 5 years worldwide. ​

THE TEAM

​Prof. Diederick E. Grobbee, MD, PhD.
​Professor of Clinical Epidemiology, UMC Utrecht

Past president European Association for Preventive Cardiology, ESC.

Chief Scientific Officer, Julius Clinical Academic Research Organization
Leyla Kragten-Tabatabaie, PhD.
​​Associated Director Scientific networks, Julius Clinical Academic Research Organization

Board of Directors, ReSViNET foundation  
Dr. Joyce Browne, MD, PhD.
Assistant Professor of Global Health.

Research focus: maternal health (especially hypertensive disorders of pregnancy), clinical epidemiology and capacity building in low resource settings.
​Dr. Kerstin Klipstein-Grobusch, PhD.
Associate Professor and Academic Coordinator Global Health
Julius Center, UMC Utrecht
Research focus: non-communicable diseases; co-morbidity communicable / non-communicable diseases; research capacity building in epidemiology and public health in middle-and low income countries